Analysis of Drug Related Problems (DRPs) of Anti-Tuberculosis Drugs in a Pulmonary Tuberculosis Patient Using the SOAP Method
Siti Rouchmana, Safrina Nurjulianti, Jihan Huwaida Noor Santung, Nuraisyah Nuraisyah, Nur Hasanah, Faizah Hanan Lestari, Dinda Hidayah Multazam, Siti Nur Azizah Yahya, et al. (10 authors)
Journal Pharmasci (Journal of Pharmacy and Science) · 2024-06
Abstract
Tuberculosis is an infectious disease caused by the bacteria Mycobacterium tuberculosis. Drug Related Problem (DRP) is an undesirable event that can occur in a patient that is related to drug use so that it can interfere with achieving the expected therapeutic goals. This research is a study of a 49 year old male patient with a body weight of 45 kg and a height of 154 cm with a diagnosis of pulmonary tuberculosis who received intensive phase anti-tuberculosis drug (OAT) therapy, namely rifampicin, isoniazid, pirazinamide, ethambutol and a continuation phase, namely rifampicin and isoniazid. This study aims to analyze the DRPs of using OAT therapy in a pulmonary tuberculosis patient using the SOAP analysis method. The results of this research are that there are several DRPs that occur and are resolved with suggestions for additional therapy to overcome the side effects felt by patients as well as providing education to patients so that they continue to consume medication regularly.
MeSH terms
- Ethambutol
- Rifampicin
- Medicine
- Tuberculosis
- Isoniazid
- Drug
- Mycobacterium tuberculosis
- Pulmonary tuberculosis
- Intensive care medicine
- Antibiotics
- Pharmacotherapy
- Internal medicine
- Surgery